Stocks and Investing Stocks and Investing
Mon, November 7, 2022
Fri, November 4, 2022

Jayson Bedford Maintained (TNDM) at Buy with Decreased Target to $52 on, Nov 4th, 2022


Published on 2024-10-27 23:56:00 - WOPRAI, Jayson Bedford
  Print publication without navigation


Jayson Bedford of Raymond James, Maintained "Tandem Diabetes Care, Inc." (TNDM) at Buy with Decreased Target from $92 to $52 on, Nov 4th, 2022.

Jayson has made no other calls on TNDM in the last 4 months.



There are 5 other peers that have a rating on TNDM. Out of the 5 peers that are also analyzing TNDM, 0 agree with Jayson's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Jayson


  • Matt O'Brien of "Piper Sandler" Maintained at Buy with Decreased Target to $70 on, Thursday, November 3rd, 2022
  • Matt Miksic of "Barclays" Initiated at Buy and Held Target at $75 on, Tuesday, October 18th, 2022
  • Matthew Taylor of "Jefferies" Initiated at Strong Buy and Held Target at $75 on, Wednesday, October 12th, 2022
  • Larry Biegelsen of "Wells Fargo" Downgraded from Buy to Sell and Decreased Target to $49 on, Tuesday, August 9th, 2022
  • Lawrence Biegelsen of "Wells Fargo" Maintained at Buy with Decreased Target to $82 on, Thursday, August 4th, 2022